Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Aloxiprimum

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

73 API Suppliers, 24 USDMF, 8 CEP/COS, 2 JDMF, 2 KDMF, 24 NDC API, 29 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

257 Drugs in Development

257 Drugs in Development

FINISHED DOSAGE FORMULATIONS

679 FDF Dossiers, 117 FDA Orange Book, 303 Europe, 88 Canada, 17 Australia, 33 South Africa, 121 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, DELAYED RELEASE;ORAL - 325MG;40MG, TABLET, DELAYED RELEASE;ORAL - 81MG;40MG, TABLET;ORAL - 250MG;250MG;65MG, CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Minakem, 8 Evonik, 12 Rochem International Inc, 32 SPI Pharma, 30 DKSH, 2 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 15 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 2 Pfanstiehl, 1 Capital Farma, 12 Kirsch Pharma, 4 ACG Worldwide, 15 Actylis, 2 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 4 Ashland, 40 BASF, 1 Bioplus Life Sciences, 5 CD Formulation, 3 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 2 Esteem Industries, 3 Finar, 16 Gangwal Chemicals, 15 Ideal Cures, 5 Ingredion Pharma Solutions, 27 Kerry, 4 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 24 Microlex e.U, 1 Nanjing Bold Chemical, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 47 Roquette, 19 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

113 Fillers, Diluents & Binders, 86 Coating Systems & Additives, 69 Thickeners and Stabilizers, 55 Solubilizers, 49 Disintegrants & Superdisintegrants, 49 Direct Compression, 47 Taste Masking, 46 Controlled & Modified Release, 45 Parenteral, 42 Granulation, 38 Topical, 33 Film Formers & Plasticizers, 31 Lubricants & Glidants, 27 Chewable & Orodispersible Aids, 19 Emulsifying Agents, 18 Rheology Modifiers, 17 Co-Processed Excipients, 14 Surfactant & Foaming Agents, 12 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 194 News #PharmaBuzz

GLOBAL SALES INFORMATION

19 US Medicaid Prescriptions, 38 Regulatory FDF Prices, 11 Annual Reports

MARKET PLACE

60 APIs, 43 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 JP, 12 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Alta Laboratories	India	Alta Laboratories Ltd Khopoli IN	R1-CEP 2000-013 - Rev 01	Acetylsalicylic acid, Crystals 7010/7011, fines 7012, granules 7017/7018, granular powder 7028, PR powder 7029	2007-09-11	Withdrawn by EDQM Failure to CEP procedure	Chemical	2009-05-25	309
29/11/2025	Bayer AG	Germany	BAYER HISPANIA, S.L. Langreo ES	CEP 2001-292 - Rev 05	Acetylsalicylic acid	2025-10-14	Valid	Chemical		309

Aloxiprimum

Aloxiprimum

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

73 API Suppliers

24 USDMF

8 CEP/COS

2 JDMF

2 KDMF

24 NDC API

29 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

257 Drugs in Development

FINISHED DOSAGE FORMULATIONS

679 FDF Dossiers

117 FDA Orange Book

303 Europe

88 Canada

17 Australia

33 South Africa

121 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET, DELAYED RELEASE;ORAL - 325MG;40MG

TABLET, DELAYED RELEASE;ORAL - 81MG;40MG

TABLET;ORAL - 250MG;250MG;65MG

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

2 Minakem

8 Evonik

12 Rochem International Inc

32 SPI Pharma

30 DKSH

2 Pharm-RX Chemical

8 Boai NKY Pharmaceuticals Ltd

10 Gangwal Healthcare

15 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

2 Pfanstiehl

1 Capital Farma

12 Kirsch Pharma

4 ACG Worldwide

15 Actylis

2 Aeon Procare

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

4 Ashland

40 BASF

1 Bioplus Life Sciences

5 CD Formulation

3 Clariant

15 Corel Pharma Chem

7 DFE Pharma

3 Doshion Polyscience

2 Esteem Industries

3 Finar

16 Gangwal Chemicals

15 Ideal Cures

5 Ingredion Pharma Solutions

27 Kerry

4 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

24 Microlex e.U

1 Nanjing Bold Chemical

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

11 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons